Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Patient Name
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Randomized Controlled Study to Evaluate Prophylactic Properties of Ayurvedic Treatment Protocol in Refractory and Chronic Migraine Patients
This study compared Ayurvedic treatment to conventional therapy for chronic refractory migraine. After 360 days, the Ayurvedic group showed greater reductions in headache days, VAS, and MIDAS scores (p
Demographic Pattern of Pancreatitis Patients in India – A Hospital-based Study
A hospital-based study on 2,050 pancreatitis patients across India found that 83% were male, with an average age of 24 years, and 75% aged between 19–45. Alcohol use was reported by 33.6% and tobacco by 18.4%, while genetic and gallstone-related causes accounted for 8.8% and 5% respectively. The findings suggest emerging lifestyle and regional risk factors, but broader studies are needed for definitive insights.
Ayurvedic preparation in the treatment of nutritional anemia
A pilot study on 600 anemic women showed the highest hemoglobin gain (1.8 g%) with a combination of Ayurvedic preparations SS and Ayas, followed by Ayas (1.6 g%), SS (1.5 g%), and IFA tablets (1.1 g%). SS, a non-iron Ayurvedic preparation, improved iron absorption and showed promising results with minimal side effects.
Prevalence of Anemia among Pregnant Women and Adolescent Girls in 16 Districts of India
Nutritional anemia is widespread in India, affecting 84.9% of pregnant women and 90.1% of adolescent girls. Severe anemia is prevalent in both groups. The Government of India provides iron and folic acid to pregnant women, but no similar program exists for adolescent girls. Interventions should address iron, B12, and folic acid deficiencies.
Impact Evaluation of Ayurvedic Treatment Protocol on Three HundredNineteen Cases of Different Variants of Pancreatitis
Pancreatitis, affecting the pancreas' function, causes symptoms like pain, nausea, and weight loss. Conventional treatments are limited, prompting many to seek alternative medicine. A North India Ayurvedic clinic successfully treated 319 cases of Recurrent Acute/Chronic Pancreatitis using a specialized Ayurvedic Treatment Protocol (ATP), including the formulation Amar. This treatment improved weight and reduced attack frequency without side effects. Ongoing research is exploring its potential.
Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies
Prak-20, an ayurvedic herbo-mineral formulation, was studied for its hepato-protective effects in rats. It showed no significant liver damage or elevated enzyme levels compared to controls. In higher doses, it reduced liver enzymes by up to 54% and minimized liver damage. These results suggest Prak-20 is effective in protecting the liver, with further research needed on its mechanism.